0      0


JL1114EH - JL1114EH: Patients’ perspectives on oral decitabine and cedazuridine for the treatment of myelodysplastic syndromes


‐ Oct 23, 2023 4:00pm

Full author listing

Amer Zeidan, MD1 Kate Perepezko, PhD2 Tehseen Salimi, MD3 Terri Washington, DNP, RN3 Robert Epstein, MD4

1Yale University and Yale Cancer Center, New Haven, CT, USA; 2CorEvitas LLC, Waltham, MA, USA; 3Taiho Oncology, Inc., Princeton, NJ, USA; 4Epstein Health LLC, Woodcliff Lake, NJ, USA